Gemini Therapeutics Inc

NASDAQ:GMTX   2:50:17 PM EDT
4.61
+0.10 (+2.22%)
Earnings Announcements

Gemini Therapeutics Reports Second Quarter 2021 Financial Results And Provides Business Update

Published: 08/12/2021 11:24 GMT
Gemini Therapeutics Inc (GMTX) - Gemini Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update.
Q2 Loss per Share $0.38.
Q2 Earnings per Share Estimate $-0.40 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.44

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.49

More details on our Analysts Page.